Quetiapine Fumarate Tablet
Product Images NDC 50090-3342

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50090-3342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903333)

Label Image (Lbl500903333)
Quetiapine Fumarate 25 mg oral tablets label from A-S Medication Solutions. The label indicates a package of 30 tablets containing Quetiapine Fumarate USP equivalent to 25 mg of Quetiapine. Storage instructions specify to store at 77 degrees Fahrenheit. The label notes dosage information to see the package insert and includes NDC and lot number details.*
FDA Label Image

Lbl500903342

Lbl500903342
Quetiapine Fumarate 50 mg oral tablets packaging label by A-S Medication Solutions. The label includes product and lot numbers, dosage strength, storage instructions (store at 77 degrees F), package size of 30 tablets, and a note to see package insert for dosage information. The label also lists quetiapine fumarate USP equivalent strength and the labeler's address in Libertyville, Illinois.*
FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

Quetiapine-fig1 (Quetiapine Fig1)
Kaplan-Meier curves illustrating time to recurrence of a mood event (Study 7), showing the proportion of patients with relapse over time in weeks. Two curves compare QTP+LI/VAL and PLA+LI/VAL groups, with relapse proportions increasing at different rates for each group across the study duration up to 100 weeks.*
FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

Quetiapine-fig2 (Quetiapine Fig2)
Kaplan-Meier curves showing time to recurrence of a mood event over 100 weeks. The y-axis represents the proportion of patients with relapse (%) and the x-axis shows time in weeks. Two curves compare QTP + Li/Val (quetiapine fumarate plus lithium/valproate) versus PLA + Li/Val (placebo plus lithium/valproate).*
FDA Label Image

Structure (Quetiapine Stru)

Structure (Quetiapine Stru)
Chemical structure of quetiapine fumarate showing the quetiapine molecule and the fumarate ion as part of the salt form in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.